Most of the current studied HCC patients have AFP level < 400 as already reported by somewhere else (Shehzad et al. 2019) and therefore, the updated guidelines for the surveillance of HCC recommend ultrasound every 6 months, rather than combination of ultrasonography and AFP levels (Colombo and Sirlin 2019). Here, AFP is linked to hepatocellular carcinoma.